Algo version: 0.98b
Lupin Limited is listed at the NSE Exchange
Lupin Limited [LUPIN.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Lupin Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Lupin Limited pays dividends. Last time was Sunday 1st of September 2024 where the investors holding the stock on Tuesday 16th of July 2024 were paid INR8 per share. Over the last 25 times between 2002 and 2024, Lupin Limited has paid INR147.7 with an average of INR5.91 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Lupin Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR766.70, you would have made a profit of INR1 489.80 per share or 194.31%

Yes, the average daily trading liquidity for Lupin Limited is INR1.55 million. You should therefore be able to get in and out of your positions relatively fast.

Lupin Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.53, the company's ability to pay off the debt is good. Lupin Limited has a good net profit margin of 9.74% and should have high tolerances against inflation.

We have calculated the inflation risk for Lupin Limited to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.